Related Experiment Videos
Klazomania Refractory to Electroconvulsive Therapy: A Rare Case Report
Vishwa Thakkar1, Sagar Karia, Nilesh Shah
1Department of Psychiatry, LTMMC and GH, Sion, Mumbai.
The Journal of ECT
|August 13, 2026
Summary
Klazomania, compulsive shouting, is rare and linked to neurological disorders. A case study shows Obsessive Compulsive Disorder patients may initially improve with Electroconvulsive Therapy, but it can become ineffective.
Area of Science:
- Neurology
- Psychiatry
Background:
- Klazomania is a rare condition involving uncontrollable shouting without apparent cause.
- It is associated with various neurological and psychiatric conditions.
- The exact cause and optimal treatment for Klazomania remain unknown.
Purpose of the Study:
- To report a case of Klazomania in a patient diagnosed with Obsessive Compulsive Disorder.
- To describe the patient's response to Electroconvulsive Therapy (ECT).
Main Methods:
- Case report detailing a patient with Klazomania and Obsessive Compulsive Disorder.
- Observation of treatment response to Electroconvulsive Therapy.
Main Results:
- The patient initially showed improvement with Electroconvulsive Therapy.
- The patient's condition later became refractory to Electroconvulsive Therapy.
Conclusions:
- Electroconvulsive Therapy may offer initial benefits for Klazomania associated with Obsessive Compulsive Disorder.
- Treatment refractoriness to Electroconvulsive Therapy can occur in such cases.
- Further research is needed to understand Klazomania's etiology and develop effective treatments.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...